AI in the Lab: Hype or Hope?

Few topics divide lab managers right now like artificial intelligence. Some expect the fully self-running laboratory by next quarter. Others have had enough of "revolutionary" tools that turn out to be expensive disappointments in practice.

As so often, the truth sits somewhere in between. AI in the lab is neither the saviour nor the hype it's alternately sold as. It's a tool — with clear strengths and equally clear limits. Anyone making decisions about laboratory administration should understand both before investing.

Where AI in the lab already delivers

Let's start with the good news. There are areas where AI is no longer a distant promise but brings measurable gains in lab efficiency.

Making knowledge findable. In most labs, the critical knowledge sits in people's heads, PDF folders, and email threads. Where's the current SOP? What was the release limit for this method again? Language-based AI can search large volumes of documents and answer specific questions — with the source cited. That doesn't save seconds, it saves the half-hour otherwise lost to searching.

Preparing routine steps. Protocol drafts, first versions of reports, summaries of long test results: AI handles the tedious groundwork, the human reviews and approves. It shifts work from "typing it yourself" to "checking it" — and in a regulated environment, that's exactly the right order.

Speech instead of typing. Technically, speech recognition has long been good enough to dictate notes, readings, or observations straight into the system — reliably, even in lab jargon. What's interesting here is less the technology than the practice: this very feature is adopted only slowly by users. The reason lies less in the tool than in the human — it means a complete change in working habits. The idea of every colleague talking to a phone or tablet all day in the lab takes getting used to. It's quite possible this technology will gain importance over the next few years — namely when every last minute of efficiency gain really counts. For now: the technology is ready, the habit isn't.

Spotting patterns. In measurement series, trends across test equipment, or deviations in QC data, an algorithm often sees anomalies earlier than the human eye. Not as a replacement for expert judgement, but as an early-warning system.
‍

⚠️ Caution — especially with reports and regulated documents: The automatic generation of documents is viewed critically in the pharmaceutical world — and rightly so. In April 2026, the FDA issued its first warning letter to explicitly address the use of AI. A company had let AI agents generate specifications, SOPs, and manufacturing records — and did not have those documents reviewed by its quality unit. Asked why a required process validation was missing, the firm essentially replied that the AI had never flagged it. The FDA made it clear: using AI does not release anyone from their obligations — every AI-generated document must be reviewed and approved by qualified personnel. Responsibility cannot be delegated to an algorithm.
‍

[[image-1]]
‍

Where the hype breaks against reality

And now the limits — the ones marketing likes to leave out.

AI makes things up. Language models give answers that sound convincing even when they're wrong. In casual chat that may not matter. In a lab where an invented limit value has real consequences, it's a deal-breaker. Without solid source-binding and human control, generative AI has no place in critical processes.

Regulation doesn't forgive a black box. Anyone working under ISO 17025, GxP, or similar frameworks has to be able to trace how a result came about. A system that can't explain its decision is a problem in an audit — no matter how well it performs.

"AI" is often just a label. Not everywhere it says AI is there more than a simple rule behind it. When choosing a vendor, the concrete questions pay off: what exactly does the model do, what data was it trained on, and what happens to our data?

The honest middle ground

For lab managers, that means: don't wait for full automation, but don't jump on every bandwagon either. The pragmatic path starts where the pain is greatest and the risk smallest — usually in knowledge management and document search, not in the automatic release of test results.

An example from practice: in LabThunder, the built-in AI feature answers staff questions directly from the lab's own stored SOPs, manuals, and test instructions — always citing the source the answer came from. The key difference from a general chatbot: the answer doesn't come from the internet, but from the lab's own approved documents. That keeps it traceable what a statement rests on — exactly the traceability an audit demands. The expert decision stays with the human; the AI only shortens the path to the right information.

That's not hype. But it's also not the grand revolution some promise. It's solid, verifiable value — and that's exactly the standard to hold it to.

Conclusion

AI in the lab is hope and hype — depending on where you look. The mistake is judging it wholesale. Anyone who examines the specific use case, weighs the risk, and insists on traceability will find areas of real value today. Anyone waiting for the fully automated laboratory will be waiting a while yet.

So the right question isn't "hype or hope?" but: "for which task specifically — and can the result be verified?"